We face significant
challenges ensuring the safe,
global distribution of a
legitimate Covid-19 vaccine.
Grant Courtney looks to our
learnings throughout twenty-
plus years of developing
healthcare traceability to
highlight the key lessons we
must apply.
The first results of Covid-19 seroprevalence surveys indicate sufficient levels of herd immunity are a long way off. Given the uncertainty about the duration of such immunity, it is becoming increasingly clear that a vaccine will be key to mitigating the impact of the pandemic on society and the economy.